Innovative Approach to Treatment of the Metabolic Syndrome

作者: Joel Ricci , Michael Timoney , George Ferzli

DOI: 10.1007/978-3-642-02411-5_10

关键词: Weight lossSustained remissionMalabsorptionMetabolic syndromeIntensive care medicineObesityMedicineInsulin resistanceDiseaseDiabetes mellitus

摘要: In recent decades, we have seen a massive increase in the incidence of metabolic syndrome. With advent bariatric surgery as most effective method to achieve and maintain weight loss, multiple changes also been discovered regarding its role management diabetes There is now extensive evidence support treatment not only for obesity but well documented derangements that accompany it. The site nutrient delivery gastrointestinal tract, malabsorption, gut hormone secretion are all believed play important roles proposed mechanism action surgery. Although mechanisms longterm remission other obesity-associated co-morbidites still being outlined, novel techniques surgical innovations provided very promising results select groups patients. This chapter deals with history effects on An overview several hypotheses theories behind surgically induced may lead sustained this disease given, along discussion ongoing trials, create better understanding future patient population.

参考文章(136)
Friedman Mn, Magovern Gj, Sancetta Aj, The amelioration of diabetes mellitus following subtotal gastrectomy. Surgery gynecology & obstetrics. ,vol. 100, pp. 201- ,(1955)
Haller H, Epidermiology and associated risk factors of hyperlipoproteinemia Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete. ,vol. 32, pp. 124- 128 ,(1977)
Edward E. Mason, Chikashi Ito, Gastric Bypass in Obesity Surgical Clinics of North America. ,vol. 47, pp. 1345- 1351 ,(1967) , 10.1016/S0039-6109(16)38384-0
P. Zimmet, J. Shaw, K. G. M. M. Alberti, Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: A realistic view Diabetic Medicine. ,vol. 20, pp. 693- 702 ,(2003) , 10.1046/J.1464-5491.2003.01052.X
Jean-Pierre Gutzwiller, Jürgen Drewe, Burkhard Göke, Harald Schmidt, Beat Rohrer, Jürg Lareida, Christoph Beglinger, Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 276, ,(1999) , 10.1152/AJPREGU.1999.276.5.R1541
Yukari Date, Masayasu Kojima, Hiroshi Hosoda, Akira Sawaguchi, Muhtashan S. Mondal, Tatsuo Suganuma, Shigeru Matsukura, Kenji Kangawa, Masamitsu Nakazato, Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. ,vol. 141, pp. 4255- 4261 ,(2000) , 10.1210/ENDO.141.11.7757
Christoph Buettner, Evan D Muse, Andrew Cheng, Linghong Chen, Thomas Scherer, Alessandro Pocai, Kai Su, Bob Cheng, Xiasong Li, Judith Harvey-White, Gary J Schwartz, George Kunos, Luciano Rossetti, Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nature Medicine. ,vol. 14, pp. 667- 675 ,(2008) , 10.1038/NM1775
John Chalmers, Mark E. Cooper, UKPDS and the Legacy Effect The New England Journal of Medicine. ,vol. 359, pp. 1618- 1620 ,(2008) , 10.1056/NEJME0807625
Alberto Patriti, Maria Cristina Aisa, Claudia Annetti, Angelo Sidoni, Francesco Galli, Ivana Ferri, Nino Gullà, Annibale Donini, How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery. ,vol. 142, pp. 74- 85 ,(2007) , 10.1016/J.SURG.2007.03.001
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt, Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation. ,vol. 91, pp. 301- 307 ,(1993) , 10.1172/JCI116186